Equities

Belluscura PLC

BELL:LSE

Belluscura PLC

Health CareMedical Equipment and Services
  • Price (GBX)7.75
  • Today's Change0.00 / 0.00%
  • Shares traded99.06k
  • 1 Year change-80.38%
  • Beta--
Data delayed at least 20 minutes, as of Apr 26 2024 15:10 BST.
More ▼

Profile data is unavailable for this security.

About the company

Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.

  • Revenue in GBP (TTM)962.89k
  • Net income in GBP-8.01m
  • Incorporated2015
  • Employees24.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BELL:LSE since
announced		Transaction
value
TMT Acquisition PLCAnnounced03 Oct 202303 Oct 2023Announced-74.59%6.77m
Data delayed at least 20 minutes, as of Apr 26 2024 15:10 BST.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Surgical Innovations Group Plc12.01m-509.00k4.67m90.004.67m90.00
Myhealthchecked PLC14.95m189.00k5.20m15.005.20m15.00
Rua Life Sciences PLC1.87m-1.87m6.67m40.006.67m40.00
Advanced Oncotherapy PLC0.00-32.60m9.50m174.009.50m174.00
Belluscura PLC962.89k-8.01m12.81m24.0012.81m24.00
Ondine Biomedical Inc470.97k-10.96m13.27m43.0013.27m43.00
Inspiration Healthcare Group PLC41.08m-550.00k21.49m210.0021.49m210.00
SDI Group PLC68.07m1.61m56.46m489.0056.46m489.00
Inspecs Group PLC203.29m-997.00k57.95m1.67k57.95m1.67k
Data as of Apr 26 2024. Currency figures normalised to Belluscura PLC's reporting currency: UK Pound GBX

Institutional shareholders

10.18%Per cent of shares held by top holders
HolderShares% Held
Dowgate Wealth Ltd.as of 04 Apr 20247.48m4.55%
Lombard Odier Asset Management (Europe) Ltd.as of 15 Nov 20236.45m3.93%
Rathbones Asset Management Ltd.as of 09 Feb 20242.23m1.35%
Avellemy Ltd.as of 29 Mar 2024574.88k0.35%
More ▼
Data from 31 Dec 2023 - 29 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.